Quotes 5-day view End-of-day quote Shanghai Stock Exchange
08/08/2022
08/09/2022
08/10/2022
08/11/2022
08/12/2022
Date
31.92
31.67
30.88
31.09
30.36
Last
3144707
2286101
3124546
3394645
2608369
Volume
-2.00%
-0.78%
-2.49%
+0.68%
-2.35%
Change
Estimated financial data (e) CNY USD
Sales 2022
19 899 M
2 951 M
2 951 M
Net income 2022
1 009 M
150 M
150 M
Net cash position 2022
511 M
75,8 M
75,8 M
P/E ratio 2022
24,9x
Yield 2022
1,64%
Sales 2023
24 905 M
3 694 M
3 694 M
Net income 2023
1 325 M
196 M
196 M
Net cash position 2023
773 M
115 M
115 M
P/E ratio 2023
21,1x
Yield 2023
2,18%
Capitalization
28 815 M
4 273 M
4 273 M
EV / Sales 2022
1,42x
EV / Sales 2023
1,13x
Nbr of Employees
38 353
Free-Float
33,4%
DaShenLin Pharmaceutical Group Co., Ltd. is a China-based company principally engaged in the pharmaceutical retailing business. The Company's primary business includes direct sales and retailing of Chinese and Western medicine, ginseng nourishing herbs and Chinese medicine pieces, health products, medical apparatus and instruments and other commodities. The Company mainly conducts its business within domestic market.
Ratings of DaShenLin Pharmaceutical Group Co., Ltd.
All news about DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
06/22 Beijing Mulls Banning Internet Healthcare Firms From Selling Drugs Online MT
05/06 UBS Adjusts Dashenlin Pharmaceutical's Price Target to 40 Yuan From 73.5 Yuan, Keeps at.. MT
04/27 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End.. CI
04/27 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter.. CI
2021 DaShenLin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months E.. CI
2021 Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year End.. CI
2021 Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter.. CI
2021 Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End.. CI
2020 DaShenLin Pharmaceutical Group Co., Ltd. cancelled the acquisition of 51% stake in Nant.. CI
2020 Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months E.. CI
2020 Secretive High-Speed Trading Firm Hits Jackpot With TikTok DJ
2020 Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year End.. CI
2020 Certain A Shares of DaShenLin Pharmaceutical Group Co., Ltd. are subject to a Lock-Up A.. CI
2020 DaShenLin Pharmaceutical Group Co., Ltd. Announces Cash Dividend for the Year 2019, Pay.. CI
2020 Dashenlin Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year End.. CI
News in other languages on DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
Analyst Recommendations on DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
Chart DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends DASHENLIN PHARMACEUTICAL GROUP CO., LTD.
Short Term Mid-Term Long Term Trends Neutral Bullish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
10
Last Close Price
30,36 CNY
Average target price
39,33 CNY
Spread / Average Target
29,5%
Please enable JavaScript in your browser's settings to use dynamic charts.